Eric James Duncavage MD

PubMed

• Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursors.
  Felicia Gomez, Lauren Shea, Sivasankar Annamalai Sharavanan, David Russler-Germain, Matthew Mosior
  Cancer Genetics. 2026-06-01
• Proactive identification of candidates for newly approved targeted therapies using a clinical decision support program.
  Rebecca Feldman, Farah Abdulla, Andrew Hinton, James Hamrick, Bobby Hill
  The Oncologist. 2026-05-08
• 1 citations
  Analytical validation of a scrape-free multitarget stool RNA test for colorectal cancer screening.
  Erica K Barnell, Kimberly Kruse, Elizabeth M Wurtzler, Maya Crowder Scott, Andrew R Barnell
  Practical Laboratory Medicine. 2025-12-01

Journal Articles

• TP53 Immunohistochemistry Correlates TP53 Mutation Status and Clearance in Decitabine-Treated Patients with Myeloid Malignancies  
  John S Welch, Eric J Duncavage, Haematologica
• Exome Analysis of Treatment‐Related AML After APL Suggests Secondary Evolution  
  John S Welch, Eric J Duncavage, Meagan A Jacoby, Peter Westervelt, Lukas D Wartman, British Journal of Haematology
• Discriminating a Common Somatic ASXL1 Mutation (c.1934dup; p.G646Wfs*12) from Artifact in Myeloid Malignancies Using NGS  
  Jonathan W Heusel, Richard D Press, Matthew J Walter, Eric J Duncavage, Nature

Abstracts/Posters

• TGF-_ Signaling Contributes to Myelofibrosis and Clonal Dominance of Myeloproliferative Neoplasms
  Eric J. Duncavage, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019